Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Myszkowski Kenneth Allen Create: Alert

All | News | Filings
Date FiledTypeDescription
06/29/2023 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $36.2, valued at $543k
01/05/2023 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 60,000 shares @ $0
12/30/2022 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 30,625 shares @ $40, valued at $1.2M
01/06/2022 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 15,908 shares @ $60.5, valued at $962.4k
Sold 16,528 shares @ $62, valued at $1M
Sold 3,778 shares @ $63.17, valued at $238.7k
Sold 3,786 shares @ $63.95, valued at $242.1k
01/04/2022 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 60,000 shares @ $0
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2020 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 25,840 shares @ $69.04, valued at $1.8M
Sold 17,665 shares @ $69.86, valued at $1.2M
Exercised 43,505 options to buy @ $14.54, valued at $632.6k
10/22/2020 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 29,166 shares @ $54.04, valued at $1.6M
Exercised 29,166 options to buy @ $6.15, valued at $179.4k
02/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2020 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 6,397 shares @ $47.07, valued at $301.1k
Sold 6,432 shares @ $47.93, valued at $308.3k
Sold 10,554 shares @ $49.07, valued at $517.9k
Sold 2,800 shares @ $49.98, valued at $139.9k
Sold 10,680 shares @ $51.11, valued at $545.9k
Sold 3,450 shares @ $52.13, valued at $179.8k
Exercised 33,351 options to buy @ $5.19, valued at $173.1k
01/08/2020 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 7,593 shares @ $59.6, valued at $452.5k
Sold 11,907 shares @ $60.4, valued at $719.2k
Sold 500 shares @ $60.95, valued at $30.5k
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/07/2019 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 12,649 options to buy @ $5.19, valued at $65.6k
11/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2019 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 15,000 options to buy @ $4.6, valued at $69k
Exercised 20,000 options to buy @ $5.19, valued at $103.8k
05/22/2019 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 27,071 shares @ $22, valued at $595.6k
02/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2019 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 81,875 shares @ $14.55, valued at $1.2M
01/03/2019 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 85,000 shares @ $0
Sold 8,333 shares @ $11.98, valued at $99.8k
09/10/2018 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 25,000 shares @ $18, valued at $450k
Sold 20,000 shares @ $21.01, valued at $420.2k
Exercised 25,000 options to buy @ $2.62, valued at $65.5k
Exercised 20,000 options to buy @ $4.75, valued at $95k
06/20/2018 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 20,000 shares @ $14.01, valued at $280.2k
Exercised 20,000 options to buy @ $2.01, valued at $40.2k
06/01/2018 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 1,400 shares @ $11, valued at $15.4k
Sold 12,600 shares @ $11, valued at $138.6k
Exercised 1,400 options to buy @ $2.01, valued at $2.8k
Exercised 12,600 options to buy @ $2.01, valued at $25.3k
03/27/2018 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 20,000 shares @ $8, valued at $160k
Exercised 20,000 options to buy @ $2.01, valued at $40.2k
03/05/2018 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 8,208 shares @ $6.66, valued at $54.7k
01/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
08/24/2016 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 13,100 shares @ $8, valued at $104.8k
Sold 6,900 shares @ $8, valued at $55.2k
Exercised 13,100 options to buy @ $2.01, valued at $26.3k
Exercised 6,900 options to buy @ $2.01, valued at $13.9k
03/08/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/09/2016 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD RESEARCH CORP
Txns: Paid exercise price by delivering 13,048 shares @ $3.46, valued at $45.1k
05/08/2013 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD RESEARCH CORP
Txns: Granted 90,000 options @ $2.01, valued at $180.9k
10/02/2012 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD RESEARCH CORP
Txns: Granted 25,000 options @ $2.62, valued at $65.5k
02/21/2012 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD RESEARCH CORP
Txns: Granted 83,000 options @ $5.19, valued at $430.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy